Becton, Dickinson and Company (BDX)
(Delayed Data from NYSE)
$236.18 USD
+0.49 (0.21%)
Updated Nov 30, 2023 04:00 PM ET
After-Market: $236.09 -0.09 (-0.04%) 7:58 PM ET
4-Sell of 5 4
D Value B Growth C Momentum C VGM
Price, Consensus and EPS Surprise
BDX 236.18 +0.49(0.21%)
Will BDX be a Portfolio Killer in December?
Zacks Investment Research is releasing its prediction for BDX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for BDX
BD (BDX) Q4 Earnings In-Line With Estimates, Margins Contract
Here's What Key Metrics Tell Us About Becton Dickinson (BDX) Q4 Earnings
BDX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Unlocking Q4 Potential of Becton Dickinson (BDX): Exploring Wall Street Estimates for Key Metrics
BD (BDX) Gears Up for Q4 Earnings: What's in the Offing?
Becton Dickinson (BDX) Reports Next Week: Wall Street Expects Earnings Growth
Other News for BDX
FDA Safety Communication Does Not Impact BD Syringes
Insider Sell: EVP & President Interventional Richard Byrd Sells Shares of Becton Dickinson ...
7 Blue-Chip Stocks to Buy for 2024, According to AI
BD Launches Advanced Vascular Access Ultrasound System Designed to Improve Clinician Efficiency
Becton Dickinson reports FDA safety communication doesn't impact BD syringes